4,373 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Semanteon Capital Management LP

Semanteon Capital Management LP acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,373 shares of the medical technology company’s stock, valued at approximately $778,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. HighTower Advisors LLC boosted its holdings in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after buying an additional 66 shares in the last quarter. Hengehold Capital Management LLC boosted its holdings in Teleflex by 7.3% during the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after buying an additional 88 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. Avior Wealth Management LLC lifted its holdings in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 101 shares in the last quarter. Finally, Isthmus Partners LLC lifted its holdings in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after purchasing an additional 105 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on TFX shares. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Morgan Stanley reduced their price target on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Truist Financial reduced their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and cut their price objective for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Finally, Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, Teleflex currently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Stock Performance

Shares of TFX stock opened at $141.77 on Friday. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a 50 day moving average price of $163.17 and a 200 day moving average price of $194.40. The firm has a market capitalization of $6.57 billion, a price-to-earnings ratio of 28.19, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.